Abstract Purpose: To evaluate the antibacterial activity and cytotoxicity of a series of molecules with amalgamation of furoyl, piperazine and amide moieties.
INTRODUCTION
There are wide possibilities for the utilization of furan derivatives as biologically active compounds. Piperazine derivatives are known to possess the properties of triple reuptake inhibitors [1] , norovirus inhibitors [2] , cannabinoid CB1 receptor agonists [3] , antagonists for the melanocortin-4 receptor [4] , antimicrobials [5] , enzyme inhibitors [6] , etc. This moiety has also found applications in the field of engineering [7] and polymers [8] . The amides are known to possess valuable biological activities [9] [10] [11] .
These valuable biological activities of furan and amide moieties prompted us to introduce some new molecules with the amalgamation of these moieties and to evaluate their potential as antibacterial agents.
EXPERIMENTAL General
Chemicals and solvents were from Sigma Aldrich and Alfa Aesar and purchased through a local supplier. All solvents were further used without purification. A Griffin and George melting point apparatus was utilized to read the melting points of synthesized compounds, and melting points were uncorrected. Thin layer chromatography (TLC) run on silica-coated aluminum plates helped to confirm product formation. The mobile phase was a mixture of ethyl acetate and nhexane and spots were visualized under a UV lamp at 254 nm. A Jasco-320-A spectrometer was used to record IR peaks by the KBr pellet method. Bruker spectrometers were used to record 1 H-NMR signals at 500 MHz in CHCl 3 -d 1 , and a JMS-HX-110 spectrometer recorded EIMS signals.
General procedure for synthesis of Naryl/aralkyl-3-bromopropanamides (3a-u)
A calculated amount of substituted aryl/aralkyl/alkyl amines (1a-u; 15.0 mmol) was placed in a 250-mL iodine flask containing distilled water (15.0 mL) and 10 % Na 2 CO 3 . The pH was adjusted to 9-10. 3-Bromopropionyl chloride (2; 15.0 mmol) was then added dropwise to the reaction mixture for 2-5 min. A solid precipitate appeared on vigorous shaking. TLC was used to monitor the reaction progress. The products, N-(aryl/aralkyl/alkyl)-3-bromopropanamides (3a-u), were collected by filtration and washed and dried.
General procedure for synthesis of 3-[4-(2-furoyl)-1-piperazinyl]-N-(aryl/aralkyl/alkyl) propanamides (5a-u)
4-(2-Furoyl)-1-piperazine (4; 0.1 g, 4.5 mmol) and solid K 2 CO 3 (13.5 mmol) were dissolved in acetonitrile (18 mL) in a round-bottom flask (100 mL). After refluxing for 0.5 h, the electrophiles Naryl/aralkyl/alkyl-3-bromopropanamides (3a-u; 4.5 mmol) were added and refluxing was continued for 3-4 h. The reaction was monitored by TLC. The final compounds were acquired after the addition of excess distilled water, and the precipitate was filtered out, washed and dried. 
Reagents and conditions
(I) 10 % sodium carbonate, pH = 9 -10, stir for 3 -4 h, room temperature; (II) acetonitrile, potassium carbonate, reflux for 0.5 h; and (III) reflux for 3 -4 h. 4' 
Antibacterial activity assay
The broth microdilution method was employed to evaluate the antibacterial activity of the synthesized compounds. The synthesized compounds at different concentrations were mixed with selected bacterial strains, and the change in absorbance before and after incubation was noted [12, 13] .
Evaluation of hemolytic activity
Hemolytic activity was studied using a previously reported method [14, 15] . A blood sample was collected from a cow, and red blood cells (RBCs) were isolated for use. Triton X-100 and phosphate buffer saline (PBS) were employed as the positive and negative controls, respectively.
Statistical analysis
Microsoft Excel 2010 was utilized for statistical analysis of results which were expressed as mean ± SEM (n = 3). 
RESULTS

The
3-[4-(2-Furoyl
d, J = 8.3 Hz, 2H, H-2''', H-6'''), 7.12 (d, J = 8.2 Hz, 2H, H-3''', H-5'''), 7.05 (d, J = 3.5 Hz, 1H, H-3'), 6.05 (dd, J = 1.7, 3.4 Hz, 1H, H-4'), 3.91 (br.s, 4H, CH 2 -3, CH 2 -5), 2.78 (t, J = 6.2 Hz, 2H, CH 2 -2''), 2.67 (m, 4H, CH 2 -2, CH 2 -4), 2.56 (t, J = 6.2 Hz, 2H, CH 2 -3''), 2.31 (s, 3H, CH 3 -7'''); EIMS (m/z): 341 [M] + ,
3-[4-(2-Furoyl)-1-piperazinyl]-Nbenzylpropanamide (5e)
Light-brown, sticky amorphous solid; yield: 90 %; Mol. 
3-[4-(2-Furoyl)-1-piperazinyl]-N-(2-ethylphenyl) propanamide (5g)
Light
3-[4-(2-Furoyl)-1-piperazinyl]-Ntetrahydrofuran-2-ylmethylpropanamide (5m)
3-[4-(2-Furoyl)-1-piperazinyl]-N-(2,3-dimethylphenyl) propanamide (5n)
3-[4-(2-Furoyl)-1-piperazinyl]-N-(2,4-dimethylphenyl) propanamide (5o)
3-[4-(2-Furoyl)-1-piperazinyl]-N-(2,5-dimethylphenyl) propanamide (5p)
Off 
3-[4-(2-Furoyl)-1-piperazinyl]-N-(2,6-dimethylphenyl)propanamide (5q)
3-[4-(2-Furoyl
3-[4-(2-Furoyl)-1-piperazinyl]-N-(3,5-dimethylphenyl) propanamide (5s)
3-[4-(2-Furoyl)-1-piperazinyl]-N-(5-chloro-2-methoxyphenyl) propanamide (5u)
Light-brown amorphous solid; yield: 90 %; m. 
Antibacterial and hemolytic activities
All synthesized molecules were screened against Gram-positive and Gram-negative bacteria and were found to be good to excellent inhibitors. The results are given as % inhibition and MIC values in Tables 1 and 2 . The % hemolysis of the synthesized compounds is also given in Table 2 .
The results for compounds were compared with that for Triton X-100 and phosphate-buffered saline (PBS). propanamides (5a-u) were synthesized to introduce new promising antibacterial agents with mild cytotoxicity. The synthesis has been outlined in scheme 1 and structures of these targeted molecules are shown in Figure 1 . The procedures of synthesis and conditions of reactions are described in the experimental section. The structural assignment of one of the compounds is described hereby for clear understanding of interpretational decorum of the synthesized compounds. propanamides showed notable activity against both Grampositive and Gram-negative bacterial strains compared to ciprofloxacin. A comparison of the two compounds 5a bearing an unsubstituted phenyl group and 5l bearing an aliphatic cyclohexyl group showed that 5a was more active against S. typhi, E. coli and S. aureus, but 5l, more against P. aeruginosa and B. subtilis. The presence of an aromatic system at the nitrogen of the propanamoyl group had a positive effect on the bioactivity of the synthesized molecule. The hemolysis results for compound 5a showed that it is more toxic than 5l. The increase in the distance of the unsubstituted phenyl ring from the nitrogen of the amidic group resulted in an increase in bioactivity potential but this effect was found to be the reverse for a too long aliphatic chain. Therefore, compound 5e bearing a benzyl group was found to be more active than 5a bearing a phenyl group, but 5f bearing a phenylethyl group was the least active.
Furthermore, 5e was the least toxic compound among these three. No considerable difference in bioactivity potential was found between the three compounds 5b-d, bearing a methyl-substituted phenyl group at the ortho, meta and para positions. When a 2-methylphenyl group (compound 5b) was replaced by a 2-ethylphenyl group (compound 5g), the bioactivity potential was found to be increased and also with low toxicity. The presence of an ethoxy group at the ortho position of the phenyl ring (5i) did not favor higher bioactivity.
A similar order of bioactivity was found for 4-methylphenyl (compound 5d) and 4-ethylphenyl (compound 5h), but 5h was more toxic. 4-Ethoxyphenyl (compound 5j) had a little less antibacterial activity compared to 5h but it possessed much less toxicity. This shows that the substitution of ethyl at the ortho position of the phenyl ring (compound 5g) resulted in more activity with low toxicity as compared to that at the para position (compound 5h). A similar pattern of bioactivity was observed for the ethoxy group at the ortho and para positions. Among those with dimethylphenyl groups, compounds 5n-q, bearing one methyl at the ortho position and a second at other positions turned out to be less effective compared to compounds 5r and 5s, bearing one methyl at the meta position and a second at other positions. Among compounds 5n-q, 5n was the most active, but it showed high toxicity. The other three showed comparable potential, with no considerable effect of variation in position of substitution. Both compounds 5r and 5s also showed a similar order of activity.
Overall, all synthesized molecules showed impressive antibacterial activity against S. typhi. The aromatic rings were responsible for more interaction, and the alkyl groups in better positions accounted for higher antibacterial activity. The compounds exhibiting low toxicity could be further subjected to in vivo study to assess their application in a drug design program.
CONCLUSION
The findings of this study show that almost all the derivatives are active against all the strains of Gram-positive and Gram-negative bacteria tested. Only a few of the synthesized molecules possess moderate cytotoxicity. Thus, these molecules have some potential as therapeutic agents, but further studies are required in this regard.
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